Dana is a computational biology and translational data science leader who built and led multidisciplinary teams across academia, biotech, and pharma, translating large-scale biological data into actionable translational insights in oncology, neuroscience, cardiometabolic, and rare disease. Prior to joining the Wyss, Dana served as Sr. Director of Data & Analytics Engineering at Novo Nordisk, leading global teams building multimodal data platforms for target and biomarker discovery. Earlier, she was Director of Genome Platform Development and Instructor of Medicine at Harvard Medical School and Brigham and Women’s Hospital, Sr. Director of Biomedical Informatics at KEW, Inc., and co-Director at Brigham Genomic Medicine. Dana earned her PhD in Computational Biology from the Weizmann Institute of Science and completed her postdoctoral training in Computational Genetics at Brigham and Women’s Hospital and Harvard Medical School.